Breast cancer drug approved for NHS after maker agrees discount
by Sarah Marsh from Science | The Guardian on (#5N7RC)
Reversal of earlier rejection by Nice of abemaciclib - known as Verzenios - is welcomed by campaigners
A breast cancer drug that was rejected for routine NHS use in England earlier this year has now been recommended by health officials after a discount was agreed with the manufacturer.
The decision has been described as fantastic news for thousands of women" by a charity, which said the introduction of this drug would give precious extra months" for those who are very unwell.
Continue reading...